14 Sept 2015
Although acute adverse events associated with zoledronic acid infusion in paediatric patients with bone disorders are common, they mainly occur after the initial infusion and are generally mild and easily managed, according to recent findings published in the Journal of Clinical Endocrinology and Metabolism.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024